Aether Industries Ltd
Incorporated in 2013, Aether Industries Limited is a manufacturer of specialty chemicals. The company is sole Indian manufacturer for chemicals such as 4-(2-Methoxyethyl) Phenol (4MEP), and 3-Methoxy-2-Methylbenzoyl Chloride (MMBC), Thiophene-2-Ethanol (T2E), Ortho Tolyl Benzo Nitrile (OTBN), N-Octyl-D-Glucamine, Delta-Valerolactone, and Bifenthrin Alcohol.[1]
- Market Cap ₹ 10,931 Cr.
- Current Price ₹ 824
- High / Low ₹ 1,071 / 737
- Stock P/E 65.4
- Book Value ₹ 168
- Dividend Yield 0.00 %
- ROCE 10.2 %
- ROE 7.80 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company is expected to give good quarter
Cons
- Stock is trading at 4.91 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 8.44% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of BSE Commodities BSE SmallCap BSE 400 MidSmallCap Index BSE Allcap BSE 250 SmallCap Index
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
590 | 651 | 598 | 839 | |
422 | 465 | 466 | 598 | |
Operating Profit | 168 | 186 | 132 | 241 |
OPM % | 28% | 29% | 22% | 29% |
7 | 17 | 25 | 30 | |
Interest | 13 | 5 | 9 | 13 |
Depreciation | 15 | 23 | 40 | 45 |
Profit before tax | 146 | 174 | 110 | 213 |
Tax % | 26% | 25% | 25% | 26% |
109 | 130 | 82 | 158 | |
EPS in Rs | 9.67 | 10.47 | 6.22 | 11.95 |
Dividend Payout % | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 12% |
TTM: | 40% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 15% |
TTM: | 81% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -1% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 8% |
Last Year: | 8% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
Equity Capital | 113 | 125 | 133 | 133 |
Reserves | 274 | 1,120 | 1,931 | 2,093 |
291 | 16 | 183 | 200 | |
92 | 120 | 154 | 218 | |
Total Liabilities | 770 | 1,380 | 2,401 | 2,644 |
257 | 646 | 853 | 1,125 | |
CWIP | 58 | 37 | 232 | 355 |
Investments | 17 | 1 | 0 | 0 |
438 | 695 | 1,315 | 1,163 | |
Total Assets | 770 | 1,380 | 2,401 | 2,644 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
-5 | -7 | -16 | 100 | |
-151 | -348 | -424 | -418 | |
169 | 439 | 894 | 2 | |
Net Cash Flow | 12 | 84 | 453 | -316 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
Debtor Days | 101 | 145 | 142 | 126 |
Inventory Days | 221 | 301 | 411 | 324 |
Days Payable | 95 | 99 | 124 | 104 |
Cash Conversion Cycle | 227 | 348 | 429 | 346 |
Working Capital Days | 183 | 269 | 384 | 319 |
ROCE % | 18% | 7% | 10% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
24h - Audio recording of Q4 and FY2025 earnings call made available on company website.
-
Integrated Filing (Financial)
1d - Aether Industries reports FY25 audited results: revenue Rs 8,387m, profit Rs 1,584m, fire loss disclosed as exceptional item.
-
Intimation For Search Conducted By Surat CE & GST Commissionerate
2d - Surat GST search found Rs.14.4L tax liability plus penalty, promptly settled by Aether Industries.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
30 Apr - Earnings call scheduled on May 3, 2025, to discuss Q4 financial performance.
-
Board Meeting Intimation for Consideration And Approval Of Agenda Points On May 2, 2025
26 Apr - Board meeting on May 2, 2025, to approve FY25 Q4 audited financial results.
Annual reports
Concalls
-
May 2025TranscriptNotesPPT
-
Jan 2025Transcript PPT REC
-
Jan 2025TranscriptNotesPPT
-
Oct 2024Transcript PPT REC
-
Jul 2024TranscriptPPT
-
Jul 2024Transcript PPT
-
May 2024Transcript PPT
-
May 2024TranscriptNotesPPT
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT REC
-
Jul 2023Transcript PPT
-
Jun 2023Transcript PPT
-
May 2023TranscriptNotesPPT
-
Jan 2023Transcript PPT
-
Jan 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Jul 2022Transcript PPT
-
Jun 2022Transcript PPT
Business Segments FY24[1]
Large Scale Manufacturing (59%) Advanced intermediates and specialty chemicals with application across the industry spectrum.
Contract Manufacturing (26%)
Manufacture under contractual supply agreements with MNCs.
CRAMS (14%)
Contract research, scale-up services, technology development, low volume high-value contract manufacturing.